Mice: Heterozygous mice were first interbred to produce homozygous (cd73 -/-, n=10) and wild type (WT) littermate (n=6) for 2 weeks TAC procedure, and results showed that TAC caused significantly more ventricular hypertrophy and dysfunction in cd73 -/as compared with WT littermates (p<0.05). We subsequently used cd73 -/mice and their WT littermates as breeders to generate offspring for TAC procedure cd73 -/-, n=13; WT mice, n=9). Data for heart weight and lung weight was pooled from initial experiments using cd73 -/and wild type littermates, as well as the offspring of cd73 -/and WT mice. The data of aortic pressure, ventricular pressure and dP/dt was collected from offspring of cd73 -/and WT mice. All of the data is expressed as Mean ± standard error.
5'-AMP induced decrease of heart rate. It is known that extracellular adenosine stimulates adenosine A1 receptors to cause dose dependent bradycardia 1 . Since CD73 uses 5'-AMP as a substrate to generate adenosine, to determine whether CD73 KO disrupts extracellular adenosine production in vivo, we determined the bradycardiac response to 5'-AMP in a group of CD73 KO and wild type mice as previously described 2 . Briefly, mice were anesthetized with 1.5% isoflurane and the left jugular vein cannulated for bolus injections of 5 to 30 µg of 5'-AMP while the heart rate was observed. The effect of 5'-AMP on heart rate was also assessed in a group of A1AR KO mice 1 Histological staining and measurement of myocardial fibrosis. Tissue sections (6µm) from the central portion of the LV were stained with Sirius Red (Sigma) for detection of fibrosis, and FITC-conjugated wheat germ agglutinin (AF488, Invitrogen) to evaluate myocyte size. For mean myocyte size, the cross sectional area of at least 120 cells/sample (from 4 areas) and at least 4 samples of each group were averaged. The percent volume fibrosis was determined using the method described previously 3 .
Western blots.
Protein content was analyzed using Western blots as previously described 3 . Western blots were performed using primary antibodies against ANP(Penninsula Laboritories;San Carlos, CA), type I collagen and β-MHC(Sigma; St Louis MO), TNFα, total-Akt, p-Akt Ser473 , p-S6 Ser235/236 , PTEN, p-PTEN ser380 , total p70S6K, p-p70S6K Thr389 , mTOR and p-mTOR (Cell Signaling Technology; Beverly, MA), followed by visualization using HRP-labeled secondary antibodies (Bio-Rad; Hercules, CA) Protein concentration was measured using BioRad Protein Assay(Biorad; Hercules, Ca) and equal amounts of soluble protein were separated on 10% polyacrylamide gels for western blot analysis. Scanning densitometry and Image J software was used to quantify band intensity. experiments. Cells fixed as described above were also used for immunocytochemical analysis of ANP expression, using primary rabbit anti-ANP, followed by Alexa-fluor 488 anti-rabbit (Molecular Probes)
Neonatal fibroblast isolation, culture, and [3H]-leucine and proline incorporation
Myocytes were separated from cardiac fibroblasts by low speed centrifugation(500 rpm).The supernate was centrifuged at 2200 rpm to collect fibroblasts. Fibroblasts were initially plated on 75 cm 2 flasks in 10% FCS in DMEM, passaged twice, and replated in 24 well plates at a density of 1x10 4 /cm 2 in 0.2% FCS in DMEM. After 48 hrs, fresh serum free media was added containing 1µCi/ml [H 3 ]-Proline or 1µCi/ml [H 3 ]-Leucine(Amersham;Piscataway, NJ), to measure collagen production and total protein synthesis, respectively 5 . Cells were treated in triplicate with the indicated concentrations of adenosine for 15 minutes prior to addition of 2.5% FCS. Tritium incorporation was measured at 48 hrs by washing cells twice in PBS, precipitation in 10% TCA for ten minutes at 23°C, followed by solubilization in 0.3N NaOH, 0.1%SDS at 37ºC for 2hrs. 
